We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+8.96%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.6B
AUM Growth
+$1.15B
(+1.6%)
Cap. Flow
-$3.6B
Cap. Flow
% of AUM
-4.89%
Top 10 Holdings %
Top 10 Hldgs %
20.8%
Holding
3,102
New
50
Increased
790
Reduced
2,114
Closed
100
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$38.7M |
| 2 |
International Flavors & Fragrances
IFF
|
+$27.4M |
| 3 |
Neurocrine Biosciences
NBIX
|
+$14.7M |
| 4 |
ConocoPhillips
COP
|
+$14.5M |
| 5 |
Royalty Pharma
RPRX
|
+$9.46M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$269M |
| 2 |
Microsoft
MSFT
|
+$172M |
| 3 |
Amazon
AMZN
|
+$114M |
| 4 |
Walt Disney
DIS
|
+$62.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$61.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.61% |
| 2 | Financials | 14.26% |
| 3 | Healthcare | 12.86% |
| 4 | Consumer Discretionary | 12.27% |
| 5 | Industrials | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GOCO
2576
DELISTED
GoHealth
GOCO
| $410K | ﹤0.01% |
2,340
+126
| +6% | +$25.4K |
|
|
CNBKA
2577
DELISTED
Century Bancorp Inc/Mass
CNBKA
| $408K | ﹤0.01% |
4,373
-150
| -3% | -$13.1K |
|
|
SIEN
2578
DELISTED
Sientra, Inc.
SIEN
| $407K | ﹤0.01% |
5,585
-433
| -7% | -$27.6K |
|
2579
Farmers & Merchants Bancorp
FMAO
$481M
| $406K | ﹤0.01% |
16,142
-530
| -3% | -$13K |
|
2580
Limoneira
LMNR
$251M
| $406K | ﹤0.01% |
23,206
-1,535
| -6% | -$25.4K |
|
2581
Superior Group of Companies
SGC
$225M
| $406K | ﹤0.01% |
15,973
-530
| -3% | -$13.2K |
|
2582
Cue Biopharma
CUE
$114M
| $404K | ﹤0.01% |
1,103
-61
| -5% | -$25.1K |
|
2583
Greenlight Captial
GLRE
$506M
| $404K | ﹤0.01% |
46,400
-1,740
| -4% | -$14.2K |
|
2584
Clearfield
CLFD
$374M
| $403K | ﹤0.01% |
13,376
-650
| -5% | -$20.6K |
|
2585
Puma Biotechnology
PBYI
$454M
| $403K | ﹤0.01% |
41,489
-3,780
| -8% | -$42.2K |
|
|
DMTK
2586
DELISTED
DermTech, Inc. Common Stock
DMTK
| $402K | ﹤0.01% |
+7,909
| New | +$414K |
|
|
MRNS
2587
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $402K | ﹤0.01% |
25,976
-618
| -2% | -$8.94K |
|
|
LITS
2588
Lite Strategy Inc
LITS
$30.9M
| $399K | ﹤0.01% |
5,810
-107
| -2% | -$7.48K |
|
|
VXRT
2589
DELISTED
Vaxart
VXRT
| $398K | ﹤0.01% |
65,783
-5,522
| -8% | -$42.5K |
|
|
PFBI
2590
DELISTED
Premier Financial Bancorp
PFBI
| $398K | ﹤0.01% |
21,409
-380
| -2% | -$6.08K |
|
|
AGS
2591
DELISTED
PlayAGS
AGS
| $397K | ﹤0.01% |
49,096
-1,590
| -3% | -$11.3K |
|
2592
Ceco Environmental
CECO
$4.14B
| $397K | ﹤0.01% |
50,032
-1,530
| -3% | -$12.1K |
|
2593
Airbnb
ABNB
$107B
| $396K | ﹤0.01% |
+2,107
| New | +$390K |
|
|
AKRO
2594
DELISTED
Akero Therapeutics
AKRO
| $396K | ﹤0.01% |
13,650
-750
| -5% | -$22.7K |
|
|
EMWP
2595
DELISTED
Eros Media World PLC
EMWP
| $391K | ﹤0.01% |
10,787
-168
| -2% | -$6.75K |
|
2596
Peabody Energy
BTU
$2.9B
| $390K | ﹤0.01% |
127,537
-3,370
| -3% | -$12.7K |
|
2597
Tilly's
TLYS
$128M
| $390K | ﹤0.01% |
34,442
-1,460
| -4% | -$15.6K |
|
2598
Franklin Covey
FC
$246M
| $389K | ﹤0.01% |
13,750
-710
| -5% | -$18.6K |
|
2599
MediaAlpha
MAX
$821M
| $389K | ﹤0.01% |
10,983
+1,681
| +18% | +$83.3K |
|
2600
SIGA Technologies
SIGA
$219M
| $388K | ﹤0.01% |
59,724
-3,560
| -6% | -$24.1K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2021 Portfolio in Review
As of Q1 2021, RhumbLine Advisers held 3,102 positions worth $73.6B, up 1.6% from $72.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
RhumbLine Advisers withdrew a net $3.6B in Q1 2021, closing 100 positions and reducing 2,114 holdings. Its most notable exit was Tiffany & Co., an estimated $26.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
Against the trend, RhumbLine Advisers opened a new position in NXP Semiconductors worth $42.7M.
- RhumbLine Advisers's largest Q1 2021 buy was NXP Semiconductors: 211,843 shares worth $42.7M.
- RhumbLine Advisers added most to International Flavors & Fragrances in Q1 2021, an estimated $27.4M increase.
- RhumbLine Advisers's biggest Q1 2021 reduction was Apple, cutting an estimated $269M.
- RhumbLine Advisers fully exited Tiffany & Co. in Q1 2021, selling an estimated $26.8M.
- RhumbLine Advisers's ten largest holdings make up 21% of its $73.6B portfolio in Q1 2021.
- RhumbLine Advisers opened 50 new positions and closed 100 in Q1 2021.
- RhumbLine Advisers's portfolio value rose 1.6% quarter-over-quarter to $73.6B.
Based on RhumbLine Advisers's 13F filing for Q1 2021, filed 6 May 2021.